Stenotrophomonas maltophilia in the respiratory tract of medical intensive care unit patients

European Journal of Clinical Microbiology and Infectious Diseases

Volumn 31, Issue 7, 2012, Pages 1419-1428

  Saugel, B ^a   Eschermann, K ^a   Hoffmann, R ^b   Hapfelmeier, A ^a   Schultheiss, C ^a   Phillip, V ^a   Eyer, F ^a   Laugwitz, K L ^a   Schmid, R M ^a   Huber, W ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b UNIVERSITY OF MUNICH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CARBAPENEM DERIVATIVE; CEFTAZIDIME; CEPHALOSPORIN DERIVATIVE; CIPROFLOXACIN; COTRIMOXAZOLE; MOXIFLOXACIN; PIPERACILLIN; POLYMYXIN B; SULBACTAM; TIGECYCLINE; VANCOMYCIN; ANTIINFECTIVE AGENT;

ADULT; AGED; ANTIBIOTIC SENSITIVITY; ARTICLE; ARTIFICIAL VENTILATION; BACTERIAL COLONIZATION; BACTERIAL PNEUMONIA; BACTERIUM ISOLATION; CRITICALLY ILL PATIENT; FEMALE; FOLLOW UP; HUMAN; IMMUNE DEFICIENCY; INTENSIVE CARE UNIT; KIDNEY FAILURE; LUNG INJURY SCORE; MAJOR CLINICAL STUDY; MALE; MORTALITY; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; PRIORITY JOURNAL; RESPIRATORY TRACT INFECTION; RETROSPECTIVE STUDY; RISK FACTOR; SEQUENTIAL ORGAN FAILURE ASSESSMENT SCORE; STENOTROPHOMONAS MALTOPHILIA; DRUG EFFECT; GRAM NEGATIVE INFECTION; ISOLATION AND PURIFICATION; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY; MIDDLE AGED; PATHOLOGY; RESPIRATORY SYSTEM; SURVIVAL;

ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; FEMALE; GRAM-NEGATIVE BACTERIAL INFECTIONS; HUMANS; INTENSIVE CARE UNITS; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; PNEUMONIA, BACTERIAL; RESPIRATORY SYSTEM; RETROSPECTIVE STUDIES; RISK FACTORS; STENOTROPHOMONAS MALTOPHILIA; SURVIVAL ANALYSIS;

EID: 84865594498     PISSN: 09349723     EISSN: 14354373     Source Type: Journal    
DOI: 10.1007/s10096-011-1459-8     Document Type: Article

References (40)

1. Hugh R, Ryschenkow E (1961) Pseudomonas maltophilia, an alcaligenes-like species. J Gen Microbiol 26:123-132
2. Vincent JL, Sakr Y, Sprung CL, Ranieri VM, Reinhart K, Gerlach H, Moreno R, Carlet J, Le Gall JR, Payen D (2006) Sepsis in European intensive care units: Results of the SOAP study. Crit Care Med 34(2):344-353
3. Kang CI, Kim SH, Park WB, Lee KD, Kim HB, Kim EC, Oh MD, Choe KW (2005) Bloodstream infections caused by antibiotic-resistant gram-negative bacilli: Risk factors for mortality and impact of inappropriate initial antimicrobial therapy on outcome. Antimicrob Agents Chemother 49(2):760-766
4. Looney WJ, Narita M, Muhlemann K (2009) Stenotrophomonas maltophilia: An emerging opportunist human pathogen. Lancet Infect Dis 9(5):312-323
5. Senol E (2004) Stenotrophomonas maltophilia: The significance and role as a nosocomial pathogen. J Hosp Infect 57(1):1-7
6. Sanchez MB, Hernandez A, Martinez JL (2009) Stenotrophomonas maltophilia drug resistance. Future Microbiol 4:655-660
7. Crossman LC, Gould VC, Dow JM, Vernikos GS, Okazaki A, Sebaihia M, Saunders D, Arrowsmith C, Carver T, Peters N, Adlem E, Kerhornou A, Lord A, Murphy L, Seeger K, Squares R, Rutter S, Quail MA, Rajandream MA, Harris D, Churcher C, Bentley SD, Parkhill J, Thomson NR, Avison MB (2008) The complete genome, comparative and functional analysis of Stenotrophomonas maltophilia reveals an organism heavily shielded by drug resistance determinants. Genome Biol 9(4):R74
8. Nicodemo AC, Paez JI (2007) Antimicrobial therapy for Stenotrophomonas maltophilia infections. Eur J Clin Microbiol Infect Dis 26(4):229-237
9. Ba BB, Feghali H, Arpin C, Saux MC, Quentin C (2004) Activities of ciprofloxacin and moxifloxacin against Stenotrophomonas maltophilia and emergence of resistant mutants in an in vitro pharmacokinetic-pharmacodynamic model. Antimicrob Agents Chemother 48(3):946-953
10. Zhang L, Li XZ, Poole K (2001) Fluoroquinolone susceptibilities of efflux-mediated multidrug-resistant Pseudomonas aeruginosa, Stenotrophomonas maltophilia and Burkholderia cepacia. J Antimicrob Chemother 48(4):549-552
11. Apisarnthanarak A, Mayfield JL, Garison T, McLendon PM, DiPersio JF, Fraser VJ, Polish LB (2003) Risk factors for Stenotrophomonas maltophilia bacteremia in oncology patients: A case-control study. Infect Control Hosp Epidemiol 24(4):269-274
12. Krcmery V, Trupl J, Svetlansky I (2001) Susceptibility to antimicrobial agents of Stenotrophomonas maltophilia isolated from patients with cancer and bacteremia. Clin Infect Dis 32 (11):1656
13. Micozzi A, Venditti M, Monaco M, Friedrich A, Taglietti F, Santilli S, Martino P (2000) Bacteremia due to Stenotrophomonas maltophilia in patients with hematologic malignancies. Clin Infect Dis 31(3):705-711
14. Yeshurun M, Gafter-Gvili A, Thaler M, Keller N, Nagler A, Shimoni A (2010) Clinical characteristics of Stenotrophomonas maltophilia infection in hematopoietic stem cell transplantation recipients: A single center experience. Infection 38 (3):211-215
15. Chaplow R, Palmer B, Heyderman R, Moppett J, Marks DI (2010) Stenotrophomonas maltophilia bacteraemia in 40 haematology patients: Risk factors, therapy and outcome. Bone Marrow Transplant 45 (6):1109-1110
16. Waters V, Yau Y, Prasad S, Lu A, Atenafu E, Crandall I, Tom S, Tullis E, Ratjen F (2011) Stenotrophomonas maltophilia in cystic fibrosis: Serologic response and effect on lung disease. Am J Respir Crit Care Med 183(5):635-40
17. Razvi S, Quittell L, Sewall A, Quinton H, Marshall B, Saiman L (2009) Respiratory microbiology of patients with cystic fibrosis in the United States, 1995 to 2005. Chest 136(6):1554-1560
18. Chen CY, Tsay W, Tang JL, Tien HF, Chen YC, Chang SC, Hsueh PR (2010) Epidemiology of bloodstream infections in patients with haematological malignancies with and without neutropenia. Epidemiol Infect 138 (7):1044-1051
19. Shi SH, Kong HS, Jia CK, Zhang WJ, Xu J, Wang WL, Shen Y, Zhang M, Zheng SS (2009) Risk factors for pneumonia caused by multidrug-resistant Gram-negative bacilli among liver recipients. Clin Transplant 24(6):758-65
20. Calza L, Manfredi R, Chiodo F (2003) Stenotrophomonas (Xanthomonas) maltophilia as an emerging opportunistic pathogen in association with HIV infection: A 10-year surveillance study. Infection 31(3):155-161
21. Leung C, Drew P, Azzopardi EA (2010) Extended multidrugresistant Stenotrophomonas maltophilia septicemia in a severely burnt patient. J Burn Care Res 31(6):966
22. Labarca JA, Leber AL, Kern VL, Territo MC, Brankovic LE, Bruckner DA, Pegues DA (2000) Outbreak of Stenotrophomonas maltophilia bacteremia in allogenic bone marrow transplant patients: Role of severe neutropenia and mucositis. Clin Infect Dis 30(1):195-197
23. Lai CH,WongWW, Chin C, Huang CK, Lin HH, ChenWF, YuKW, Liu CY (2006) Central venous catheter-related Stenotrophomonas maltophilia bacteraemia and associated relapsing bacteraemia in haematology and oncology patients. Clin Microbiol Infect 12 (10):986-991
24. Lai CH, Chi CY, Chen HP, Chen TL, Lai CJ, Fung CP, Yu KW, Wong WW, Liu CY (2004) Clinical characteristics and prognostic factors of patients with Stenotrophomonas maltophilia bacteremia. J Microbiol Immunol Infect 37(6):350-358
25. Elting LS, Bodey GP (1990) Septicemia due to Xanthomonas species and non-aeruginosa Pseudomonas species: Increasing incidence of catheter-related infections. Medicine (Baltimore) 69 (5):296-306
26. Friedman ND, Korman TM, Fairley CK, Franklin JC, Spelman DW (2002) Bacteraemia due to Stenotrophomonas maltophilia: An analysis of 45 episodes. J Infect 45(1):47-53
27. Nseir S, Di Pompeo C, Brisson H, Dewavrin F, Tissier S, Diarra M, Boulo M, Durocher A (2006) Intensive care unit-acquired Stenotrophomonas maltophilia: Incidence, risk factors, and outcome. Crit Care 10(5):R143
28. Hanes SD, Demirkan K, Tolley E, Boucher BA, Croce MA, Wood GC, Fabian TC (2002) Risk factors for late-onset nosocomial pneumonia caused by Stenotrophomonas maltophilia in critically ill trauma patients. Clin Infect Dis 35(3):228-235
29. Murray JF, Matthay MA, Luce JM, Flick MR (1988) An expanded definition of the adult respiratory distress syndrome. Am Rev Respir Dis 138(3):720-723
30. Falagas ME, Kastoris AC, Vouloumanou EK, Rafailidis PI, Kapaskelis AM, Dimopoulos G (2009) Attributable mortality of Stenotrophomonas maltophilia infections: A systematic review of the literature. Future Microbiol 4:1103-1109
31. Barchitta M, Cipresso R, Giaquinta L, Romeo MA, Denaro C, Pennisi C, Agodi A (2009) Acquisition and spread of Acinetobacter baumannii and Stenotrophomonas maltophilia in intensive care patients. Int J Hyg Environ Health 212 (3):330-337
32. Tseng CC, Fang WF, Huang KT, Chang PW, Tu ML, Shiang YP, Douglas IS, Lin MC (2009) Risk factors for mortality in patients with nosocomial Stenotrophomonas maltophilia pneumonia. Infect Control Hosp Epidemiol 30(12):1193-1202
33. Muder RR, Harris AP, Muller S, Edmond M, Chow JW, Papadakis K, Wagener MW, Bodey GP, Steckelberg JM (1996) Bacteremia due to Stenotrophomonas (Xanthomonas) maltophilia: A prospective, multicenter study of 91 episodes. Clin Infect Dis 22 (3):508-512
34. Kwa AL, Low JG, Lim TP, Leow PC, Kurup A, Tam VH (2008) Independent predictors for mortality in patients with positive Stenotrophomonas maltophilia cultures. Ann Acad Med Singapore 37(10):826-830
35. Elting LS, Khardori N, Bodey GP, Fainstein V (1990) Nosocomial infection caused by Xanthomonas maltophilia: A case-control study of predisposing factors. Infect Control Hosp Epidemiol 11 (3):134-138
36. Calandra GB, Brown KR, Grad LC, Ahonkhai VI, Wang C, Aziz MA (1985) Review of adverse experiences and tolerability in the first 2,516 patients treated with imipenem/cilastatin. Am J Med 78 (6A):73-78
37. Senol E, DesJardin J, Stark PC, Barefoot L, Snydman DR (2002) Attributable mortality of Stenotrophomonas maltophilia bacteremia. Clin Infect Dis 34(12):1653-1656
38. Jones RN, Pfaller MA, Marshall SA, Hollis RJ, Wilke WW (1997) Antimicrobial activity of 12 broad-spectrum agents tested against 270 nosocomial blood stream infection isolates caused by nonenteric gram-negative bacilli: Occurrence of resistance, molecular epidemiology, and screening for metallo-enzymes. Diagn Microbiol Infect Dis 29(3):187-192
39. Clark NM, Patterson J, Lynch JP 3rd (2003) Antimicrobial resistance among gram-negative organisms in the intensive care unit. Curr Opin Crit Care 9(5):413-423
40. Valdezate S, Vindel A, Loza E, Baquero F, Canton R (2001) Antimicrobial susceptibilities of unique Stenotrophomonas maltophilia clinical strains. Antimicrob Agents Chemother 45(5):1581-1584